Strategy, Advocacy & Partnering For
The Global Orphan Drug Industry

Alexander Natz is the Secretary General of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) in Brussels and advises innovative pharmaceutical and biotech companies, including start-ups, in regulatory and pricing & reimbursement matters from the EU law and German law...

I am a trained physician with an MD degree from 1982 and a PhD in human genetics from the University of Valencia, completed in 1989. From 1985 to 1988, I underwent pediatric training at the Children's Hospital of the La Fe University Hospital in Valencia, Spain, where I also specialized in...

Sara Brambilla is the Global Programme Manager at Rare Diseases International (RDI), where she leads the development of the Global Network for Rare Diseases—an initiative aimed at strengthening international collaboration, connecting specialized expertise, and fostering structured partnerships...

Veronica Lopez Gousset, MPH, has over 10 years of experience ensuring patients’ voices are represented in healthcare decision-making. She works with the patient community to better voice their needs and challenges, with health technology assessment (HTA) bodies to improve their processes for...

PharmD, PhD in cellular biochemistry and pharmacology, post-graduate degree master in Clinical Research of Medicines. Her main areas of expertise are: ethics and regulatory, informed consent and assent, health data processing for research purposes, European medicine regulatory procedures, R&D...

Senior professional with a PhD in biotechnology and over 10 years of experience across public research, pharmaceutical and medical device industries, and public healthcare institutions. Proven expertise in health innovation, clinical research ecosystems, health data governance and institutional and ...